India, Nov. 4 -- Advances in immunology, biotechnology, and regenerative medicine depend on access to high-quality human biological materials. Among these resources, umbilical cord blood has become particularly valuable because it contains diverse populations of immune and hematopoietic cells. These cells offer researchers opportunities to investigate early immune development, cellular responses, and emerging therapeutic strategies.
One important application involves isolating peripheral blood mononuclear cells (PBMCs) from cord blood. Obtaining viable PBMCs requires carefully coordinated collection, processing, preservation, and quality control procedures.
Understanding Cord Blood PBMCs
PBMCs are a group of blood cells characterized by ...